Patents by Inventor Nancy Maxfield Wilson

Nancy Maxfield Wilson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5780319
    Abstract: Liposome reagents used in assays to detect the presence or amount of an analyte in a test sample, particularly where the analyte is antiphospholipid antibodies are described. The liposome reagents comprise a liposome, a ligand chosen to bind specifically with the analyte and associated with the liposome membrane, and a haptenated component associated with the membrane of the liposome where the hapten is chosen to bind specifically to a receptor bound to a solid phase or to a label compound that is an element of a signal detection system and where the liposome reagent is prepared so that during the assay the linkage between the solid phase and ligand of the liposome reagent is maintained.
    Type: Grant
    Filed: April 19, 1996
    Date of Patent: July 14, 1998
    Assignee: Pasteur Sanofi Diagnostics
    Inventors: Nancy Maxfield Wilson, Catherine Larue
  • Patent number: 5776487
    Abstract: The present invention relates to the detection of a variety of analytes in a patient sample employing liposomes with associated ligand, where the ligand is capable of binding target analyte in that sample. In another aspect of the invention, the assays employ liposomes as a soluble support matrix where at least a portion of the support is associated with the ligand and the ligand is in a confirmation permitting it to bind to target analyte in a patient sample.
    Type: Grant
    Filed: April 19, 1996
    Date of Patent: July 7, 1998
    Assignee: Pasteur Sanofi Diagnostics
    Inventors: Nancy Maxfield Wilson, Catherine Larue